New drug may help immune system fight cancer
(HealthDay)—An experimental drug that taps the power of the body's immune system to fight cancer is shrinking tumors in patients for whom other treatments have failed, an early study shows.
Cancer
May 16, 2013 |
5 / 5 (3) |
0
|
Experimental drug beneficial in NIH trial to treat a rare sarcoma
(Medical Xpress)—Patients with advanced alveolar soft part sarcoma (ASPS), a rare cancer, achieved some control of their disease using an experimental anti-cancer drug called cediranib. The results from ...
Cancer
May 07, 2013 |
not rated yet |
0
Study finds experimental drug inhibits growth in all stages of common kidney cancer
Researchers at Mayo Clinic's campus in Florida have discovered a protein that is overly active in every human sample of kidney cancer they examined. They also found that an experimental drug designed to block the protein's ...
Cancer
Apr 30, 2013 |
not rated yet |
0
Two-pronged approach to immune activation could lead to vaccines that effectively shut down tumor expansion
Tumor cells often express proteins that set them apart from their healthy neighbors. These very same proteins can also help the immune system to recognize and destroy the cancer. Several research groups and ...
Cancer
Apr 26, 2013 |
5 / 5 (1) |
0
New kidney cancer subtypes discovered
Researchers with the Institute of Urologic Oncology and the Department of Urology at UCLA have classified kidney cancer into several unique subtypes, a finding that will help physicians tailor treatment to ...
Cancer
Apr 16, 2013 |
5 / 5 (1) |
0
|
Protein's well-known cousin sheds light on its gout-linked relative
Johns Hopkins scientists have found out how a gout-linked genetic mutation contributes to the disease: by causing a breakdown in a cellular pump that clears an acidic waste product from the bloodstream. By comparing this ...
Medical research
Apr 08, 2013 |
not rated yet |
0
|
Kidney sparing surgery underutilized for patients who need it most
Researchers at the University of California, San Diego School of Medicine have released study results that show national treatment trends in the surgical management of patients with kidney disease. The study found that partial ...
Surgery
Mar 25, 2013 |
not rated yet |
0
'Watch and wait' approach often best for older patients with kidney cancer
(HealthDay)—Sometimes, simply watching and waiting is a safe alternative to surgery for older patients with small kidney tumors, a new study suggests.
Cancer
Feb 13, 2013 |
not rated yet |
0
Reassuring evidence: Anticancer drug does not accelerate tumor growth after treatment ends
Studies in animals have raised concerns that tumors may grow faster after the anticancer drug sunitinib is discontinued. But oncologists and physicists who collaborated to analyze data from the largest study ...
Cancer
Feb 07, 2013 |
not rated yet |
0
Rice-cell cocktail kills cancer cells, leaves normal cells alone
(Medical Xpress)—Juice from rice cells knocked out two kinds of human cancer cells as well or better than the potent anti-cancer drug Taxol in lab tests conducted by a Michigan Technological University ...
Cancer
Jan 14, 2013 |
4.9 / 5 (8) |
0
|
Kidneys sometimes removed unnecessarily due to misdiagnosis of genetic disorder
Thousands of individuals have had kidneys removed unnecessarily because doctors misdiagnosed their disease.
Diseases, Conditions, Syndromes
Jan 10, 2013 |
not rated yet |
0
Hard-to-treat Myc-driven cancers may be susceptible to drug already used in clinic
Drugs that are used in the clinic to treat some forms of breast and kidney cancer and that work by inhibiting the signaling molecule mTORC1 might have utility in treating some of the more than 15 percent of human cancers ...
Cancer
Dec 14, 2012 |
not rated yet |
0
New technique for minimally invasive robotic kidney cancer surgery
Urologists at Henry Ford Hospital have developed a new technique that could make minimally invasive robotic partial nephrectomy procedures the norm, rather than the exception for kidney cancer patients. The technique spares ...
Surgery
Dec 13, 2012 |
5 / 5 (2) |
0
Black patients with kidney cancer have poorer survival than whites
Among patients with the most common form of kidney cancer, whites consistently have a survival advantage over blacks, regardless of patient and tumor characteristics or surgical treatment. That is the conclusion of a new ...
Cancer
Nov 12, 2012 |
not rated yet |
0
Renal cancer cells target of new bark-derived drug
(Medical Xpress)—Associate Professor Joe W. Ramos, PhD, a cancer biologist at the University of Hawai'i Cancer Center in collaboration with Assistant Professor William Chain, PhD, from the UH Mānoa's Chemistry Department ...
Cancer
Nov 05, 2012 |
not rated yet |
0
